Stock Information
Vanda Pharmaceuticals Inc (VNDA)
Ticker Symbol: VNDA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $526.55 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.7362
Revenue (TTM): $3.66 M
Dividend Yield: N/A%
ROE: -49.24%
Latest News
-
FDA Grants Vanda Pharma's Request For Formal Evidentiary Public Hearing To Review CDER Proposal To Refuse Approval Of sNDA For HETLIOZ In Treatment Of Jet Lag Disorder
Tue, Mar 3, 2026 9:17 AM
-
European Medicines Agency Announced Recommended Refusal Of Marketing Authorization For Iloperidone Vanda Pharmaceuticals For Schizophrenia And Manic Or Mixed Episodes Associated With Bipolar I Disorder
Fri, Feb 27, 2026 6:56 AM
-
Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug
Wed, Feb 25, 2026 11:56 AM
-
Vanda Pharmaceuticals Announces FDA Accepts Its Biologics License Application For Generalized Pustular Psoriasis Treatment
Wed, Feb 25, 2026 8:31 AM
-
FDA Accepts Vanda's New Drug Application For Rare, Life-Threatening Skin Disease
Wed, Feb 25, 2026 8:22 AM
Key Financials
Financial data not available
